TempraMed Technologies (FRA:9DY) General and Admin. Expense: €3.55 Mil (TTM As of Mar. 2026)


FRA:9DY TempraMed Technologies Ltd FRA:9DY
1 GF Score
Price €0.30
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies General and Admin. Expense?

TempraMed Technologies FRA:9DY -14.16% 1 General and Admin. Expense is €3.55 Mil as of Mar. 2026. GuruFocus rates FRA:9DY with a GF Score™ of 1/100. The stock has 5 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. TempraMed Technologies's General and Admin. Expense for the three months ended in Mar. 2026 was €1.62 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €3.55 Mil.

TempraMed Technologies General and Admin. Expense Related Terms

TempraMed Technologies General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies General and Admin. Expense Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
General and Admin. Expense
0.00 1.49 2.32

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only 0.35 0.21 0.97 0.75 1.62
FRA:9DY
1GF Score
TempraMed Technologies Ltd FRA:9DY
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €3.55 Mil mean?
TempraMed Technologies (FRA:9DY) has a General and Admin. Expense of €3.55 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on TempraMed Technologies and its competitors.
Is TempraMed Technologies' General and Admin. Expense too high?
TempraMed Technologies' current General and Admin. Expense is €3.55 Mil. Overall, TempraMed Technologies has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' General and Admin. Expense compare to ABT and SYK?
TempraMed Technologies' General and Admin. Expense of €3.55 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current General and Admin. Expense is €3.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current General and Admin. Expense of €3.55 Mil. The current General and Admin. Expense is €3.55 Mil. TempraMed Technologies' overall GF Score™ is 1/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current General and Admin. Expense is €3.55 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
1GF Score

Get the complete analysis for FRA:9DY

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price